# Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

> **NCT01332890** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Sequence 1
- **OTHER:** Sequence 2
- **OTHER:** Sequence 3
- **OTHER:** Sequence 4
- **OTHER:** Sequence 5
- **OTHER:** Sequence 6

## Key facts

- **NCT ID:** NCT01332890
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332890, "Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01332890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*